3,5-Dimethoxyaniline
Product Information
Molecular Formula
C8H11NO2
Molecular Weight
153.18
Description
3,5-Dimethoxyaniline (CAS# 10272-07-8) is a compound useful in organic synthesis.
Synonyms
3,5-dimethoxyaniline
IUPAC Name
3,5-dimethoxyaniline
SMILES
COC1=CC(=CC(=C1)N)OC
InChI
InChI=1S/C8H11NO2/c1-10-7-3-6(9)4-8(5-7)11-2/h3-5H,9H2,1-2H3
InChI Key
WNRGWPVJGDABME-UHFFFAOYSA-N
Boiling Point
178 °C (20 mmHg)
Melting Point
54-57 °C
Flash Point
135 °C (C.C)
Purity
95 %
Density
1.096 g/cm3
Appearance
White to beige-brownish powder or needles
Storage
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
LogP
1.86720
Safety Information
Hazards
H302 H315 H319 H335
Precautionary Statement
P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P312, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501
Signal Word
Warning
Computed Properties
XLogP3
1.3
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
3
Rotatable Bond Count
2
Exact Mass
153.078978594 g/mol
Monoisotopic Mass
153.078978594 g/mol
Topological Polar Surface Area
44.5Ų
Heavy Atom Count
11
Formal Charge
0
Complexity
107
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| CN-113527311-A | FGFR4 inhibitor, composition and application thereof in preparation of medicines | 2021-08-23 |
| CN-113583262-A | Near-infrared response hyaluronic acid hydrogel for articular cartilage repair and preparation method thereof | 2021-06-24 |
| CN-113264521-A | Azobenzene-three-dimensional carbon nano hybrid film and preparation method and application thereof | 2021-05-31 |
| CN-113293615-A | Fibrous membrane preparation method for enriching circulating tumor cells, fibrous membrane and application | 2021-05-24 |
| CN-113293615-B | Fibrous membrane preparation method for enriching circulating tumor cells, fibrous membrane and application | 2021-05-24 |
| CN-113200938-A | Benzisothiazole hypoxia inducible factor 2 agonist compound or pharmaceutically acceptable salt thereof, preparation method and application | 2021-05-20 |
| CN-112920178-A | Compound with benzimidazole structure and preparation method and application thereof | 2021-01-29 |
| CN-112480109-A | Pyrido [2,3-b ] pyrazine-3 (4H) -ketone derivatives and application thereof | 2020-11-16 |
| CN-113173864-A | Graphene synergistic photo-thermal energy storage composite material and preparation method and application thereof | 2020-10-30 |
| CN-113174241-A | Graphene synergistic heat storage composite material and preparation method and application thereof | 2020-10-29 |
Literatures
| PMID | Publication Date | Title | Journal |
|---|---|---|---|
| 22346902 | 2012-02-01 | 1-(3,5-Dimeth-oxy-phen-yl)-2-(4-fluoro-phen-yl)-4,5-dimethyl-1H-imidazole | Acta crystallographica. Section E, Structure reports online |
| 21578232 | 2009-10-03 | Redetermination of ethyl (3a-cis)-3a,8b-dihydr-oxy-2-methyl-4-oxo-3a,8b-dihydro-4H-indeno[1,2-b]furan-3-carboxyl-ate monohydrate | Acta crystallographica. Section E, Structure reports online |
| 16880654 | 2006-08-01 | Synthesis and cytotoxic activity of benzo[a]pyrano[3,2-h] and [2,3-i]xanthone analogues of psorospermine, acronycine, and benzo[a]acronycine | Chemical & pharmaceutical bulletin |
